Alvotech Reveals Action Date For Interchangeable Adalimumab BLA

FDA Has Accepted AVT02 BLA For Review Including New Data

 
• By Dean Rudge
  
Interchangeable Swap Icon
Alvotech: we would have exclusivity for the higher concentration • Source: ValentinT / Alamy Stock Photo

More from Biosimilars

More from Products